borderline significantp = 0.05
The online ward, but not the F2F or control wards showed increased number of good diabetes days (GDD) from median (IQR) 4.7 (2.7–7.0) at baseline/rollout to 6.0 (2.3–7.0) in the post-intervention phase ( p = 0.04), along with increased hypos treated appropriately by ward staff (80% vs 85%, p = 0.026) and total hypos (10% vs 16%, p = 0.043), while severe hypos was borderline significant (3% vs 6%, p = 0.05).